The Flowr Corporation Stock

Equities

FLWPF

CA34354X1087

Pharmaceuticals

Market Closed - OTC Markets 03:47:13 2024-05-08 pm EDT 5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for The Flowr Corporation 0.00% -99.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2020 7.51 Sales 2021 12.35 Capitalization 22.37M
Net income 2020 -126M Net income 2021 -85M EV / Sales 2020 16,546,858 x
Net Debt 2020 29.2M Net Debt 2021 17.1M EV / Sales 2021 3,196,178 x
P/E ratio 2020
-0.35 x
P/E ratio 2021
-0.24 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 65.85%
More Fundamentals * Assessed data
Dynamic Chart
1 month
0.00
Extreme 0
0.00
Current year
0.00
Extreme 0
0.00
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.28
5 years
0.00
Extreme 0
5.78
10 years
0.00
Extreme 0
6.30
More quotes
The Flowr Corporation is a Canada-based cannabis company. The principal activity of the Company is the production and sale of premium cannabis in Canada, and medical cannabis products in other legal global markets, primarily Portugal and the European Union. It is focused on producing, marketing, and distributing dried cannabis flower products, such as packaged dried cannabis flower and pre-rolls, and intends to offer product formats such as cannabis oils, vape technology, edibles, beverages and topical products. The Company primarily operates through two segments: Flowr Canada, which is a licensed producer operating in Canada, and Holigen, which is a licensed producer with operations primarily in Portugal. Its brands include Flowr and FlowrRX. Its subsidiaries include The Flowr Canada Holdings ULC, Holigen Holdings Limited, Holigen Limited, The Flowr Group (Okanagan) Inc., RPK Biopharma Unipessoal Lda, TCann Pty Ltd and GreyCan Pty Ltd.
More about the company

Quarterly revenue - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW